Operating
Other Noncash Income (Expense)
AbbVie Other Noncash Income (Expense) increased by 144.4% to $22.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 229.4%, from -$17.00M to $22.00M. Over 3 years (FY 2021 to FY 2025), Other Noncash Income (Expense) shows a downward trend with a -75.9% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 8, 2026
How to read this metric
Large fluctuations may indicate one-time accounting adjustments or non-recurring non-cash events that require further investigation.
Detailed definition
This category aggregates various non-cash items that do not fit into standard categories like depreciation or stock-base...
Peer comparison
Standard line item in cash flow statements; peers use this to capture miscellaneous non-cash accounting impacts.
Metric ID:
operating_other_noncash_income_expenseHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.00M | $155.00M | $28.00M | -$128.00M | $214.00M | $65.00M | $0.00 | $128.00M | $45.00M | $46.00M | $6.00M | $33.00M | $20.00M | $22.00M | -$17.00M | -$79.00M | $90.00M | $9.00M | $22.00M |
| QoQ Change | — | >999% | -81.9% | -557.1% | +267.2% | -69.6% | -100.0% | — | -64.8% | +2.2% | -87.0% | +450.0% | -39.4% | +10.0% | -177.3% | -364.7% | +213.9% | -90.0% | +144.4% |
| YoY Change | — | — | — | — | >999% | -58.1% | -100.0% | +200.0% | -79.0% | -29.2% | — | -74.2% | -55.6% | -52.2% | -151.5% | -495.0% | +309.1% | — | +229.4% |
Range-$128.00M – $214.00M
CAGR+19.1%
Avg YoY Growth+129.5%
Median YoY Growth-55.6%
Other Noncash Income (Expense) at Other Companies
Frequently Asked Questions
- What is AbbVie's other noncash income (expense)?
- AbbVie (ABBV) reported other noncash income (expense) of $22.00M in Q1 2026.
- How has AbbVie's other noncash income (expense) changed year-over-year?
- AbbVie's other noncash income (expense) increased by 229.4% year-over-year, from -$17.00M to $22.00M.
- What is the long-term trend for AbbVie's other noncash income (expense)?
- Over 3 years (2021 to 2025), AbbVie's other noncash income (expense) has grown at a -75.9% compound annual growth rate (CAGR), from $213.00M to $3.00M.
- What does other noncash income (expense) mean?
- Miscellaneous non-cash income or expenses that impact net income but not cash flow.